Advertisement
Screener

BIOCRYST PHARMACEUTICALS, INC. (BCRX) Net Margin

BIOCRYST PHARMACEUTICALS, INC. (BCRX) Net Margin

  • 2026-06-30: Net Margin 35.92%.
  • 2026-03-31: Net Margin -461.48%.
  • 2025-12-31: Net Margin 60.47%.
  • 2025-09-30: Net Margin 8.09%.

Complete source-backed net margin history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-3035.92%
2026-03-31-461.48%
2025-12-3160.47%
2025-09-308.09%
2025-06-303.11%
2025-03-310.02%
2024-12-31-20.37%
2024-09-30-11.99%
2024-06-30-11.59%
2024-03-31-38.14%
2023-12-31-66.09%
2023-09-30-41.67%
2023-06-30-91.31%
2023-03-31-77.54%
2022-12-31-89.94%
2022-09-30-56.08%
2022-06-30-89.82%
2022-03-31-148.62%
2021-12-31-37.70%
2021-09-30-143.44%
2021-06-30-86.47%
2021-03-31-337.29%
2020-12-31-1506.30%
2020-09-30-755.74%
2020-06-30-1344.72%
2020-03-31-779.58%
2019-12-31-6.60%
2019-09-30-2117.86%
2019-06-30-2598.69%
2019-03-31-527.50%
2018-12-31-1005.20%
2018-09-30-2035.56%
2018-06-30-147.64%
2018-03-31-648.31%
2017-12-31-502.39%
2017-09-30-172.76%
2017-06-30-544.89%
2017-03-31-150.67%
2016-12-31-50.13%
2016-09-30-148.50%
2016-06-30-340.11%
2016-03-31-473.69%
2015-12-31-394.07%
2015-09-30-133.08%
2015-06-3018.97%
2015-03-31-222.15%
2014-12-31-214.32%
2014-09-30-269.64%
2014-06-30-999.25%
2014-03-31-293.15%
2013-12-31-51.38%
2013-09-30-334.91%
2013-06-30-1482.58%
2013-03-31-126.79%
2012-12-31-269.52%
2012-09-30-168.37%
2012-06-30-291.59%
2012-03-31-49.52%
2011-12-31-252.53%
2011-09-30-275.46%
2011-06-30-435.64%
2011-03-31-239.69%
2010-12-31-61.11%
2010-09-30-90.53%
2010-06-30-133.84%

Annual Net Margin

DateNet Margin
2025-12-3130.16%
2024-12-31-19.72%
2023-12-31-68.36%
2022-12-31-91.24%
2021-12-31-117.11%
2020-12-31-1026.35%
2019-12-31-222.99%
2018-12-31-490.25%
2017-12-31-261.18%
2016-12-31-209.25%
2015-12-31-89.15%
2014-12-31-332.08%
2013-12-31-173.72%
2012-12-31-148.64%
2011-12-31-289.91%
2010-12-31-54.27%
2009-12-31-18.03%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43